Table 4. Association of NSP score with adverse events after HR in the training and validation cohorts.
| Training cohort (n=255)a |
Validation cohort (n=169)b |
|||||
|---|---|---|---|---|---|---|
| NSP score points | ⩽1 N (%) | >1 N (%) | ⩽1 N (%) | >1 N (%) | PT-value | PV-value |
|
AE⩾grade 3 within 90 days after HR | ||||||
| Present | 7 (5.6) | 18 (13.8) | 4 (4.7%) | 11 (13.3) | 0.027 | 0.049 |
| Absent | 118 (94.4) | 112 (86.2) | 82 (95.3) | 72 (86.7) | ||
Abbreviations: AE=adverse events; HR=hepatic resection.
a
NSP score⩽1: ascites/pleural effusion (n=4), infection (n=2), haemorrhage (n=1); NSP score>1: ascites/pleural effusion (n=10), liver dysfunction=4, haemorrhage (n=3), bile leakage (n=1).
b
NSP score⩽1: ascites/pleural effusion (n=3), bile leakage (n=1); NSP score>1: ascites/pleural effusion (n=7); liver dysfunction=2, haemorrhage (n=2).